VEGFA and neoplasm: Additionally, n–3 PUFAs supplementation inhibit cancer progression inducing tumor-associated M2-like macrophages and their CSF-1R, MMP-9 and VEGF expression when compared to n–6 PUFA treatment, and therefore, increased their potential to stimulate angiogenesis.